SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Feb-23 4:12 PM View: | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 150,000 | -- | -- | 26% 569.78K to 719.78K | |
24-Feb-22 4:28 PM View: | Xeris Biopharma Holdings, I... (XERS) | 22-Feb-22 | Option Exercise | 11,228 | $0.69 | $7,747.32 | 2% 569.78K to 581.01K | |
24-Feb-22 4:28 PM View: | Xeris Biopharma Holdings, I... (XERS) | 22-Feb-22 | Planned Option Sale | 11,228 | $2.42 | $27,158.30 | (2%) 581.01K to 569.78K | |
05-Jan-22 6:15 PM View: | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 75,000 | -- | -- | 15% 494.78K to 569.78K | |
05-Oct-21 5:34 PM View: | Xeris Pharmaceuticals Inc (XERS) | 05-Oct-21 | Disposition | 494,780 | -- | -- | (100%) 494.78K to 0 | |
05-Oct-21 7:46 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Oct-21 | Grant | 494,780 | -- | -- | 100% 0 to 494.78K | |
13-Apr-21 5:06 PM View: | Xeris Pharmaceuticals Inc (XERS) | 12-Apr-21 | Market Sale (Planned) | 10,000 | $4.07 | $40,725.00 | (2%) 506.82K to 496.82K | 3% |
01-Feb-21 4:17 PM View: | Xeris Pharmaceuticals Inc (XERS) | 29-Jan-21 | Grant | 100,000 | -- | -- | 25% 406.82K to 506.82K | |
15-Jan-21 4:03 PM View: | Xeris Pharmaceuticals Inc (XERS) | 13-Jan-21 | Market Sale (Planned) | 10,000 | $6.01 | $60,058.00 | (2%) 416.82K to 406.82K | 15% |
12-Jan-21 4:02 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Jan-21 | Market Sale (Planned) | 10,000 | $5.72 | $57,244.00 | (2%) 426.82K to 416.82K | 11% |
17-Dec-20 4:40 PM View: | Xeris Pharmaceuticals Inc (XERS) | 16-Dec-20 | Gift | 10,000 | -- | -- | (2%) 436.82K to 426.82K | |
02-Mar-20 4:57 PM View: | Xeris Pharmaceuticals Inc (XERS) | 31-Jan-20 | Grant | 15,000 | -- | -- | 4% 421.82K to 436.82K | |
14-Jan-20 4:40 PM View: | Xeris Pharmaceuticals Inc (XERS) | 13-Jan-20 | Market Sale (Planned) | 10,000 | $5.50 | $54,992.00 | (2%) 431.82K to 421.82K | 8% |
20-Nov-19 4:44 PM View: | Xeris Pharmaceuticals Inc (XERS) | 19-Nov-19 | Gift | 17,500 | -- | -- | (4%) 449.32K to 431.82K | |
16-Oct-19 4:27 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Oct-19 | Market Sale (Planned) | 10,000 | $7.97 | $79,746.00 | (2%) 459.32K to 449.32K | 37% |
16-Oct-19 4:27 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Jul-19 | Market Sale (Planned) | 10,000 | $12.04 | $120,395.00 | (2%) 469.32K to 459.32K | 58% |
12-Apr-19 5:23 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Apr-19 | Market Sale (Planned) | 10,000 | $9.56 | $95,649.00 | (2%) 487.02K to 477.02K | 47% |
16-Oct-19 4:27 PM View: | Xeris Pharmaceuticals Inc (XERS) | 14-Jan-19 | Market Sale (Planned) | 7,700 | $17.20 | $132,459.00 | (2%) 477.02K to 469.32K | 71% |
15-Jan-19 4:11 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Jan-19 | Sale (Planned) | 2,300 | -- | -- | (< 1%) 489.32K to 487.02K | |
02-Jan-19 6:25 PM View: | Xeris Pharmaceuticals Inc (XERS) | 26-Dec-18 | Market Option Sale | 15,720 | $15.82 | $248,738.00 | (3%) 505.04K to 489.32K | 68% |
02-Jan-19 6:25 PM View: | Xeris Pharmaceuticals Inc (XERS) | 24-Dec-18 | Option Exercise | 15,720 | $1.19 | $18,706.80 | 3% 489.32K to 505.04K | |
27-Jun-18 8:35 PM View: | Xeris Pharmaceuticals Inc (XERS) | 25-Jun-18 | Conversion | 37,362 | -- | -- | 8% 451.96K to 489.32K |